Zobrazeno 1 - 10
of 365
pro vyhledávání: '"Tam, CS"'
Autor:
Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M
Publikováno v:
Blood and Lymphatic Cancer: Targets and Therapy, Vol Volume 10, Pp 1-5 (2020)
Chaitra Ujjani, 1 Anthony Mato, 2 Brian T Hill, 3 John N Allan, 4 Erick Lansigan, 5 Ryan Jacobs, 6 Hande Tuncer, 7 John Pagel, 8 Danielle Brander, 9 Bruce Cheson, 10 Paul Barr, 11 Lindsey E Roeker, 2 Jeffrey Pu, 12 Nirav N Shah, 13 Andre Goy, 14 Step
Externí odkaz:
https://doaj.org/article/55e83f385ab34228a9f4be53365dc63d
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S161-S161
Autor:
Brown, JR, Hillmen, P, O'Brien, S, Barrientos, JC, Reddy, NM, Coutre, SE, Tam, CS, Mulligan, SP, Jaeger, U, Barr, PM, Furman, RR, Kipps, TJ, Cymbalista, F, Thornton, P, Caligaris-Cappio, F, Delgado, J, Montillo, M, DeVos, S, Moreno, C, Pagel, JM, Munir, T, Burger, JA, Chung, D, Lin, J, Gau, L, Chang, B, Cole, G, Hsu, E, James, DF, Byrd, JC
In the phase 3 RESONATE(TM) study, ibrutinib demonstrated superior progression-free survival (PFS), overall survival (OS), and overall response rate (ORR) compared with ofatumumab in relapsed/refractory CLL patients with high-risk prognostic factors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::46e70b6f834dc8bd6475425e1a8c1a59
https://eprints.whiterose.ac.uk/118291/10/leu2017175.pdf
https://eprints.whiterose.ac.uk/118291/10/leu2017175.pdf
Autor:
Byrd, Jc, Brown, Jr, O'Brien, S, Barrientos, Jc, Kay, Ne, Reddy, Nm, Coutre, S, Tam, Cs, Mulligan, Sp, Jaeger, U, Devereux, S, Barr, Pm, Furman, Rr, Kipps, Tj, Cymbalista, F, Pocock, C, Thornton, P, Caligaris Cappio, F, Robak, T, Delgado, J, Schuster, Sj, Montillo, M, Schuh, A, de Vos, S, Gill, D, Bloor, A, Dearden, C, Moreno, C, Jones, Jj, Chu, Ad, Fardis, M, Mcgreivy, J, Clow, F, James, Df, Hillmen, P, Semenzato, GIANPIETRO CARLO
Publikováno v:
The New England journal of medicine, vol 371, iss 3
NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic abnormalities are associated with a poor outcome. We evaluated the efficacy of ibrutinib,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80208a00a4b6a2c13b3b1c7cdaabb239
http://hdl.handle.net/11577/3156149
http://hdl.handle.net/11577/3156149
Autor:
Treon, SP, Tedeschi, A, San-Miguel, J, Garcia-Sanz, R, Anderson, KC, Kimby, E, Minnema, MC, Benevolo, G, Qiu, L, Yi, S, Terpos, E, Tam, CS, Castillo, JJ, Morel, P, Dimopoulos, M, Owen, RG
Publikováno v:
Seminars in Hematology; 20230101, Issue: Preprints
Autor:
Tam, CS, Kapoor, P, Castillo, JJ, Buske, C, Ansell, SM, Branagan, AR, Kimby, E, Li, Y, Palomba, ML, Qiu, L, Shadman, M, Abeykoon, JP, Sarosiek, S, Vos, JMI, Yi, S, Stephens, D, Roos-Weil, D, Roccaro, AM, Morel, P, Munshi, NC, Anderson, KC, San-Miguel, J, Garcia-Sanz, R, Dimopoulos, MA, Treon, SP, Kersten, MJ.
Publikováno v:
Seminars in Hematology; 20230101, Issue: Preprints
Autor:
D'Sa, S, Matous, JV, Advani, R, Buske, C, Castillo, JJ, Gatt, M, Kapoor, P, Kersten, MJ, Leblond, V, Leiba, M, Palomba, ML, Paludo, J, Qiu, L, Sarosiek, S, Shadman, M, Talaulikar, D, Tam, CS, Tedeschi, A, Thomas, SK, Tohidi-Esfahani, I, Trotman, J, Varettoni, M, Vos, JMI, Garcia-Sanz, R, San-Miguel, J, Dimopoulos, MA, Treon, SP, Kastritis, E
Publikováno v:
Seminars in Hematology; 20230101, Issue: Preprints